Toth Financial Advisory Corp Kaleido Biosciences, Inc. Transaction History

Toth Financial Advisory Corp

  • $825 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 31, 2022
SELL
$2.39 - $6.02 $478 - $1,204
-200 Closed
0 $0
Q3 2020

Oct 16, 2020
BUY
$5.09 - $11.07 $254 - $553
50 Added 33.33%
200 $2,000
Q3 2019

Oct 15, 2019
BUY
$6.74 - $11.3 $1,011 - $1,695
150 New
150 $1,000

Others Institutions Holding KLDO

# of Institutions
2
Shares Held
2.65K
Call Options Held
0
Put Options Held
0
View Full List

About Kaleido Biosciences, Inc.

KLDO Quotes by TradingView
  • Ticker KLDO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,622,600
  • Description
  • Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...
More about KLDO
Track This Portfolio

Track Toth Financial Advisory Corp Portfolio

Follow Toth Financial Advisory Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Toth Financial Advisory Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email